Shenzhen Bioeasy Biotechnology Co., Ltd.

¥5.79As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300942Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (22.35%)
Div yield 0.43%
ROE (3.38%)
Biotechnology
Beta (5Y) 0.66
PE TTM —
TSR TTM (47.79%)
Mkt cap ¥2.345B
ROIC 0.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.34
26.84%
(20.38%)
Hold 7|6|11|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.10
0.10
(2.89%)
(2.36%)
4.91%
10.22%
Revenue¥M
116.0
116.6
116.0
119.8
(4.35%)
(4.66%)
(3.95%)
2.03%
Peers (US$351.6M)
Cap (US$)
PE
356.5M
14.33x
352.4M
—
Capital
TTM
5Y
10Y
Leveragex
2.956
(0.875)
(0.691)
EBIT/Intx
4.170
0.278
0.264
Own earn%
60.53
(104.75)
(121.28)
Sh yield%
15.82
17.98
20.12
Owners
Insiders/Inst%
8.82
83.05
Short interest%
2.66
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
21–24
$1 testx
—
Incr. ROIC%
10